- Home
- MBOT vs BCIC Comparison
MBOT vs BCIC Comparison
Compare MBOT & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBOT | BCIC |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.7M | 162.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MBOT | BCIC |
|---|---|---|
| Price | $2.21 | $11.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 62.1K |
| Earning Date | 03-24-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 15.70% |
| EPS Growth | N/A | ★ 330.32 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $58,080,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,119.61 | $14.87 |
| P/E Ratio | ★ N/A | $7.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.25 | $11.12 |
| 52 Week High | $4.67 | $17.51 |
Technical Indicators
Market Signals| Indicator | MBOT | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 60.99 | 41.60 |
| Support Level | $1.86 | $12.00 |
| Resistance Level | $2.37 | $12.29 |
| Average True Range (ATR) | 0.16 | 0.27 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 78.57 | 18.49 |
Price Performance
Historical ComparisonAbout MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
About BCIC BCP Investment Corporation
BCP Investment Corp is a closed-end, externally managed, non-diversified management investment company. The company invests in performing, well- established middle market businesses that operate across a wide range of industries. It employs fundamental credit analysis, targeting investments in businesses with relatively low levels of cyclicality and operating risk.